Table 3.
Health Care Providers |
• Negative perceptions of safety and efficacy |
• Negative USPSTF clinical recommendations |
• Desire to use least invasive options first (i.e. behavioral interventions) |
• Patient costs and ability to afford the drugs |
• Gaps in knowledge and limited experience |
Patients |
• Lack of insurance coverage |
• Out of pocket costs |
• Potential for adverse effects |
• Unrealistic expectations for efficacy and rapidity of benefit |